Patents by Inventor Adeleh Taghi Khani

Adeleh Taghi Khani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR DETECTING DYSFUNCTIONAL NK CELLS IN LEUKEMIA PATIENTS
    Publication number: 20250027162
    Abstract: Provided herein are, inter alia, methods for identifying dysfunctional natural killer (NK) cells in a subject with leukemia. Provided are methods for treating leukemia, including administering to the subject an effective amount of allogeneic NK cells.
    Type: Application
    Filed: May 9, 2022
    Publication date: January 23, 2025
    Inventors: Srividya SWAMINATHAN, Holden Maecker, Anil Kumar, Caroline Duault, Adeleh Taghi Khani
  • ENGINEERED NK CELLS
    Publication number: 20240016838
    Abstract: Provided herein, inter alia, are compositions including engineered NK cells and methods for preparing the same. The engineered NK cells provided herein include integrated nucleic acid sequences encoding Cas9 proteins (e.g. dCas9). The engineered NK cells are contemplated to be effective for treating and/or preventing cancer, particularly leukemia.
    Type: Application
    Filed: October 26, 2021
    Publication date: January 18, 2024
    Inventors: Srividya Swaminathan, Anil Kumar, Sung June Lee, Adeleh Taghi Khani, Chun-Wei Chen